BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 17493609)

  • 21. Hepatocyte growth factor triggers distinct mechanisms of Asef and Tiam1 activation to induce endothelial barrier enhancement.
    Higginbotham K; Tian Y; Gawlak G; Moldobaeva N; Shah A; Birukova AA
    Cell Signal; 2014 Nov; 26(11):2306-16. PubMed ID: 25101856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paxillin-beta-catenin interactions are involved in Rac/Cdc42-mediated endothelial barrier-protective response to oxidized phospholipids.
    Birukova AA; Malyukova I; Poroyko V; Birukov KG
    Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L199-211. PubMed ID: 17513457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of microtubules and Rho pathway in TGF-beta1-induced lung vascular barrier dysfunction.
    Birukova AA; Birukov KG; Adyshev D; Usatyuk P; Natarajan V; Garcia JG; Verin AD
    J Cell Physiol; 2005 Sep; 204(3):934-47. PubMed ID: 15828024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cilostazol Induces PGI2 Production via Activation of the Downstream Epac-1/Rap1 Signaling Cascade to Increase Intracellular Calcium by PLCε and to Activate p44/42 MAPK in Human Aortic Endothelial Cells.
    Hashimoto A; Tanaka M; Takeda S; Ito H; Nagano K
    PLoS One; 2015; 10(7):e0132835. PubMed ID: 26181635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rap1 mediates protective effects of iloprost against ventilator-induced lung injury.
    Birukova AA; Fu P; Xing J; Birukov KG
    J Appl Physiol (1985); 2009 Dec; 107(6):1900-10. PubMed ID: 19850733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17.
    Aslam M; Härtel FV; Arshad M; Gündüz D; Abdallah Y; Sauer H; Piper HM; Noll T
    Cardiovasc Res; 2010 Jul; 87(2):375-84. PubMed ID: 20202976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cAMP with other signaling cues converges on Rac1 to stabilize the endothelial barrier- a signaling pathway compromised in inflammation.
    Schlegel N; Waschke J
    Cell Tissue Res; 2014 Mar; 355(3):587-96. PubMed ID: 24322391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EPAC activation inhibits acetaldehyde-induced activation and proliferation of hepatic stellate cell via Rap1.
    Yang Y; Yang F; Wu X; Lv X; Li J
    Can J Physiol Pharmacol; 2016 May; 94(5):498-507. PubMed ID: 26854595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential mechanisms of adenosine- and ATPγS-induced microvascular endothelial barrier strengthening.
    Bátori R; Kumar S; Bordán Z; Cherian-Shaw M; Kovács-Kása A; MacDonald JA; Fulton DJR; Erdődi F; Verin AD
    J Cell Physiol; 2019 May; 234(5):5863-5879. PubMed ID: 29271489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
    Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
    Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rap-afadin axis in control of Rho signaling and endothelial barrier recovery.
    Birukova AA; Tian X; Tian Y; Higginbotham K; Birukov KG
    Mol Biol Cell; 2013 Sep; 24(17):2678-88. PubMed ID: 23864716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E2 activates Rap1 via EP2/EP4 receptors and cAMP-signaling in rheumatoid synovial fibroblasts: involvement of Epac1 and PKA.
    Kojima F; Kapoor M; Kawai S; Yang L; Aronoff DM; Crofford LJ
    Prostaglandins Other Lipid Mediat; 2009 Jun; 89(1-2):26-33. PubMed ID: 19464664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation.
    Garg J; Feng YX; Jansen SR; Friedrich J; Lezoualc'h F; Schmidt M; Wieland T
    Oncotarget; 2017 Jul; 8(27):44732-44748. PubMed ID: 28512254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Krev Interaction Trapped-1 in Prostacyclin-Induced Protection against Lung Vascular Permeability Induced by Excessive Mechanical Forces and Thrombin Receptor Activating Peptide 6.
    Meliton A; Meng F; Tian Y; Shah AA; Birukova AA; Birukov KG
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):834-43. PubMed ID: 25923142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells.
    Roscioni SS; Kistemaker LE; Menzen MH; Elzinga CR; Gosens R; Halayko AJ; Meurs H; Schmidt M
    Respir Res; 2009 Sep; 10(1):88. PubMed ID: 19788733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.
    Finigan JH; Dudek SM; Singleton PA; Chiang ET; Jacobson JR; Camp SM; Ye SQ; Garcia JG
    J Biol Chem; 2005 Apr; 280(17):17286-93. PubMed ID: 15710622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor.
    Rangarajan S; Enserink JM; Kuiperij HB; de Rooij J; Price LS; Schwede F; Bos JL
    J Cell Biol; 2003 Feb; 160(4):487-93. PubMed ID: 12578910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells.
    Schlegel N; Waschke J
    Am J Physiol Cell Physiol; 2009 Mar; 296(3):C453-62. PubMed ID: 19118163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1.
    Huang SK; Wettlaufer SH; Chung J; Peters-Golden M
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):482-9. PubMed ID: 18421013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids.
    Singleton PA; Chatchavalvanich S; Fu P; Xing J; Birukova AA; Fortune JA; Klibanov AM; Garcia JG; Birukov KG
    Circ Res; 2009 Apr; 104(8):978-86. PubMed ID: 19286607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.